Crozet BioPharma Announces $10.8 Million Agreement to Support Development of Single Dose Nipah Virus Vaccine Through Partnership with Public Health Vaccines The Coalition for Epidemic Preparedness Innovations (CEPI) has granted PHV funding to support pre-clinical development, manufacturing, clinical advancement through Phase 2, and establishment of an investigational stockpile of the vaccine candidate worth up to $43.6 million. PHV, a Cambridge-based biotechnology firm, has partnered with Crozet to provide core technical and strategic development services to the program.
We've got your back fam...
We've got your back fam...
We've got your back fam...
Crozet BioPharma Announces $10.8 Million Agreement to Support Development of Single Dose Nipah Virus Vaccine Through Partnership with Public Health Vaccines The Coalition for Epidemic Preparedness Innovations (CEPI) has granted PHV funding to support pre-clinical development, manufacturing, clinical advancement through Phase 2, and establishment of an investigational stockpile of the vaccine candidate worth up to $43.6 million. PHV, a Cambridge-based biotechnology firm, has partnered with Crozet to provide core technical and strategic development services to the program.